Nobrega Doris, Diaz-Castro María José, Freites-Portocarrero Aaron, Fuentes-Bielinis Luisana, Gaize-García Bill, Luna-Sánchez Valentina, Ruiz-Fernández Nelina A
Universidad de Carabobo.
Rev Fac Cien Med Univ Nac Cordoba. 2024 Dec 13;81(4):686-704. doi: 10.31053/1853.0605.v81.n4.44477.
metabolic dysfunction associated fatty liver disease (MAFLD) is a condition characterized by hepatic steatosis (HS) of metabolic origin. To predict it, HS serum indices (HSSI) have been proposed and validated, whose performance in indigenous populations is unknown.
to describe the variation of cardiometabolic risk (CMR) indicators according to four SHSI in indigenous Venezuelans of the Piaroa ethnic group, and to explore the frequency of non-alcoholic fatty liver disease (NAFLD) and MAFLD in this population.
non-experimental, descriptive, correlational and cross-sectional study, with non-probabilistic and intentional sampling, in 75 indigenous Piaroas adults (18 to 65 years). The HSSI were used: FLI (Fatty Liver Index), HSI (Liver Steatosis Index), LAP (Lipid Accumulation Product) and VAI (Visceral Adiposity Index).
FLI values were higher in men and LAP values in women. FLI, LAP and VAI were higher in individuals ≥ 40 years old. Individuals with body mass index (BMI) ≥ 25 kg/m2 showed higher FLI, HSI and LAP values compared to individuals with lower BMI. Depending on the applied HSSI, the frequency of NAFLD varied between 1.3% and 40.5%, while for MAFLD it was between 2.7 and 21.6%.
the increase in HSSI was associated with changes in CMR indicators compatible with the presence of fatty liver. The study of the metabolic profile of HS in the Piaroas indigenous people must be expanded, in order to design better focused prevention and therapeutic strategies
代谢功能障碍相关脂肪性肝病(MAFLD)是一种以代谢源性肝脂肪变性(HS)为特征的病症。为了预测该病,已经提出并验证了HS血清指标(HSSI),但其在原住民中的表现尚不清楚。
描述根据四个SHSI,在皮亚罗阿族委内瑞拉原住民中心血管代谢风险(CMR)指标的变化,并探讨该人群中非酒精性脂肪性肝病(NAFLD)和MAFLD的发生率。
采用非实验性、描述性、相关性和横断面研究,采用非概率和立意抽样,纳入75名皮亚罗阿族成年原住民(18至65岁)。使用的HSSI包括:脂肪肝指数(FLI)、肝脂肪变性指数(HSI)、脂质蓄积产物(LAP)和内脏脂肪指数(VAI)。
男性的FLI值较高,女性的LAP值较高。40岁及以上个体的FLI、LAP和VAI较高。体重指数(BMI)≥25 kg/m2的个体与BMI较低的个体相比,FLI、HSI和LAP值更高。根据所应用的HSSI,NAFLD的发生率在1.3%至40.5%之间,而MAFLD的发生率在2.7%至21.6%之间。
HSSI的升高与CMR指标的变化相关,这些变化与脂肪肝的存在相符。必须扩大对皮亚罗阿族原住民HS代谢谱的研究,以便设计更有针对性的预防和治疗策略。